Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our API

HBIO
Harvard Bioscience Inc
stock NASDAQ

Market Open
May 20, 2025 10:48:17 AM EDT
0.3400USD-1.320%(-0.0045)289,601
0.00Bid   0.00Ask   0.0000Spread
Pre-market
May 20, 2025 9:18:30 AM EDT
0.3566USD+4.636%(+0.0158)4,709
After-hours
May 19, 2025 4:00:30 PM EDT
0.3408USD+0.235%(+0.0008)0
OverviewOption ChainMax PainOptionsPrice & VolumeSplitsHistoricalExchange VolumeDark Pool LevelsDark Pool PrintsExchangesShort VolumeShort Interest - DailyShort InterestBorrow Fee (CTB)Failure to Deliver (FTD)ShortsTrendsNewsNews
Nov 3, 2021
09:16AM EDT  Harvard Bioscience Q3 EPS $0.06, Inline, Sales $29.66M Beat $27.91M Estimate   Benzinga
09:10AM EDT  Earnings Scheduled For November 3, 2021   Benzinga
07:00AM EDT  Strong double digit revenue growth, solid margin performance despite global supply chain disruptions   GlobeNewswire Inc
Oct 18, 2021
04:50PM EDT  Harvard Bioscience, Inc. (Nasdaq: HBIO) will announce its financial results for third quarter ended September 30, 2021, before the market opens on November 3, 2021, and will hold a conference call to discuss the results at 8:00 a.m. Eastern Time.   GlobeNewswire Inc
Aug 13, 2021
07:43AM EDT  The Daily Biotech Pulse: Moderna's Vaccine Produces Durable Response Against Variants, FDA Approves Jazz's Sleep Disorder Drug, Dermata IPO   Benzinga
Aug 5, 2021
07:42AM EDT  Harvard Bioscience Q2 EPS $0.06, Inline, Sales $29.20M Beat $27.67M Estimate   Benzinga
07:00AM EDT  Strong double digit revenue growth, solid margin performance despite global supply chain disruptions   GlobeNewswire Inc
04:08AM EDT  Earnings Scheduled For August 5, 2021   Benzinga
Jul 19, 2021
04:45PM EDT  Harvard Bioscience, Inc. (Nasdaq: HBIO) will announce its financial results for second quarter ended June 30, 2021 before the market opens on August 5, 2021, and will hold a conference call to discuss the results at 8:00 a.m. Eastern Time.   GlobeNewswire Inc
Jul 1, 2021
08:07AM EDT  The Daily Biotech Pulse: Spero Spikes On Pfizer Investment, FDA Nod For Jazz, Orchard Signs Licensing Deal, Acumen Pharma Debuts   Benzinga
Jun 30, 2021
07:29AM EDT  The Daily Biotech Pulse: COVID Disappointments For Altimmune And Angion, Brickell Jumps On Hyperhidrosis Study Updates, 2 IPOs   Benzinga
Jun 29, 2021
08:17AM EDT  The Daily Biotech Pulse: Sanofi Bets Big On mRNA Tech, Decision Day For MediWound, DiaMedica Issues Kidney Disease Data Readout   Benzinga
Jun 11, 2021
08:05AM EDT  The Daily Biotech Pulse: Vertex Shelves Mid-Stage Study, Precigen & Novan Jump On Data, Hematology Conference, Janux Debuts   Benzinga
May 19, 2021
11:28AM EDT  Jim Cramer Gives His Opinion On Riot Blockchain, Viacom And More   Benzinga
May 6, 2021
08:29AM EDT  Harvard Bioscience Sees Revenue Growth Of 10%-14% For FY21   Benzinga
08:29AM EDT  Harvard Bioscience Q1 EPS $0.05 Beats $0.03 Estimate, Sales $27.00M Beat $25.73M Estimate   Benzinga
07:49AM EDT  The Daily Biotech Pulse: Merck's Keytruda Snags Another FDA Approval, Moderna Slips On Revenue Miss, Chemocentryx Adcom   Benzinga
07:15AM EDT  Sales effectiveness, pre-clinical product demand and disciplined cost management result in improved revenues and margins   GlobeNewswire Inc
04:17AM EDT  Earnings Scheduled For May 6, 2021   Benzinga
Apr 30, 2021
07:31AM EDT  The Daily Biotech Pulse: Hyperphosphatemia Drug Regulatory Review Extended, Phathom Pharma Data Readout, 2 IPOs   Benzinga
Apr 28, 2021
07:26AM EDT  The Daily Biotech Pulse: FDA Rejection For Protalix, Amgen Q1 Trail Estimates, Pfizer Goes Shopping   Benzinga
Apr 19, 2021
04:55PM EDT  Harvard Bioscience, Inc. (Nasdaq: HBIO) will announce its financial results for first quarter ended March 31, 2021 before the market opens on May 6, 2021, and will hold a conference call to discuss the results at 8:00 a.m. Eastern Time.   GlobeNewswire Inc
Mar 19, 2021
07:46AM EDT  The Daily Biotech Pulse: Sarepta Gene Therapy Data, Idera Plunges On Failed Skin Cancer Study, 3 IPOs   Benzinga
Mar 18, 2021
08:16AM EDT  The Daily Biotech Pulse: Translate Bio's Cystic Fibrosis Study Disappoints, Adverum Nominates Directors, Gain Therapeutics To Debut On Nasdaq   Benzinga
Mar 17, 2021
07:43AM EDT  The Daily Biotech Pulse: Merck's Keytruda Gets Label Expansion In Europe, Pfizer To Sell Chinese Biologics Unit, Celcuity Spikes   Benzinga
Mar 16, 2021
08:17AM EDT  The Daily Biotech Pulse: Fulgent Nabs CDC Contract, Enzo Rallies, Solid Biosciences Releases Gene Therapy Data, Moderna Begins Pediatric Vaccine Study   Benzinga
Mar 12, 2021
07:36AM EST  The Daily Biotech Pulse: Novavax Vaccine Data, ContraFect Secures BARDA Funding, 2 IPOs   Benzinga
Mar 11, 2021
08:19AM EST  The Daily Biotech Pulse: Contrasting COVID-19 Treatment Readouts From Roche, Vir, Delay In Kadmon's FDA Review, Alzheimer's Data From Prothena   Benzinga
Mar 10, 2021
12:10PM EST  Harvard Bioscience: Q4 Earnings Insights   Benzinga
07:26AM EST  The Daily Biotech Pulse: MediciNova Bags BARDA Contract, Lilly's COVID-19 Antibody Cocktail Data, Bluebird Bio Refutes Blood Cancer Link   Benzinga
07:23AM EST  Harvard Bioscience: Q4 Earnings Insights   Benzinga
07:08AM EST  Harvard Bioscience Q4 Adj. EPS $0.08 Beats $0.06 Estimate, Sales $31.00M Beat $27.13M Estimate   Benzinga
07:00AM EST  -- Revenue returns to pre-Covid19 levels on strong CRO/pharma sales -- Operating margin increased year-over-year on GAAP and an adjusted basis -- New debt facility significantly reduces annual interest expense   GlobeNewswire Inc
04:04AM EST  Earnings Scheduled For March 10, 2021   Benzinga
Mar 9, 2021
10:20AM EST  Preview: Harvard Bioscience's Earnings   Benzinga
Mar 6, 2021
10:58AM EST  The Week Ahead In Biotech (March 7-13): Conference Presentations And More Earnings   Benzinga
Feb 24, 2021
07:30AM EST  The Daily Biotech Pulse: Bausch Calls Truce With Icahn, Pfizer's Brain Inflammation Vaccine Gets Priority Review, BriaCell IPO   Benzinga
Feb 9, 2021
08:10AM EST  The Daily Biotech Pulse: Dynavax Poaches GSK Vaccine Exec, KalVista Jumps On Data Readout, Corcept Issues Negative Preannouncement   Benzinga
Feb 3, 2021
07:31AM EST  The Daily Biotech Pulse: Amgen Earnings, GSK-CureVac Vaccine Collaboration, Mallinckrodt FDA Decision   Benzinga
Feb 2, 2021
08:05AM EST  The Daily Biotech Pulse: Vertex, Pfizer Earnings, Tiziana COVID-19 Vaccine Data, Decision Day For Mallinckrodt's Burn Treatment   Benzinga
Jan 26, 2021
08:07AM EST  The Daily Biotech Pulse: Novartis Misses, J&J Beats In Big Pharma Earnings, Vaccine Developer CureVac Taps Equity Market   Benzinga
Dec 23, 2020
08:31AM EST  The Daily Biotech Pulse: Supernus Issues Positive ADHD Readout, Sorrento Files For Emergency Use Authorization For Rapid COVID-19 Test, Inhibikase To Make Wall Street Debut   Benzinga
Dec 22, 2020
06:05PM EST  -- Improves liquidity and operating flexibility -- Significantly reduces borrowing costs -- Supports ongoing transformation to profitable growth platform   GlobeNewswire Inc
Dec 10, 2020
07:42AM EST  The Daily Biotech Pulse: Key Vaccine Adcom Review For Pfizer-BioNTech, Puma, Immutep, G1 Rally On Breast Cancer Conference Presentations   Benzinga
Nov 16, 2020
04:35PM EST  Harvard Bioscience, Inc. (Nasdaq: HBIO), today announced that Jim Green, Chairman, President and CEO, and Michael Rossi, CFO will participate in The Benchmark Companys 9th Annual Discovery One-on-One Conference. The virtual event will take place on Wednesday, November 18, 2020 with virtual investor meetings held throughout the day.   GlobeNewswire Inc
Nov 5, 2020
07:54AM EST  The Daily Biotech Pulse: Bluebird Bio Plunges On Regulatory Filing Delay, Synlogic Soars On Study Initiation, European Label Expansion For Vertex, Merck Goes Shopping   Benzinga
07:32AM EST  Harvard Bioscience Q3 EPS $0.04 Beats $0.03 Estimate, Sales $24.04M Miss $24.05M Estimate   Benzinga
07:00AM EST  -- Operating margin up year-over-year on GAAP and adjusted basis -- Revenue improved sequentially with solid CRO/pharma demand and academic labs reopening -- Generated positive operating cash flow in Q3 with working capital improvements   GlobeNewswire Inc
04:34AM EST  Earnings Scheduled For November 5, 2020   Benzinga
Nov 2, 2020
08:59AM EST  Morgan Stanley Maintains Equal-Weight on Rocket Companies, Lowers Price Target to $23   Benzinga
Nov 1, 2020
09:40AM EST  The Week Ahead In Biotech (Nov. 1-7): Adcom Test For Biogen's Aducanumab, Alzheimer's Conference, SMID-cap Earnings   Benzinga
Oct 20, 2020
04:45PM EDT  Harvard Bioscience, Inc. (Nasdaq: HBIO) will announce its financial results for third quarter ended September 30, 2020 before the market opens on November 5, 2020, and will hold a conference call to discuss the results on November 5, 2020 at 8:00 a.m. Eastern Time.   GlobeNewswire Inc
Sep 25, 2020
09:54AM EDT  Harvard Biosciences Shares Spike 6% Following Beta.Sam.gov Contract Filing For Dept. Of Veterans Affairs Deal For Co.'s Packwin Startle, Fear Condition System, No Terms Disclosed   Benzinga
Sep 16, 2020
04:30PM EDT  Harvard Bioscience, Inc.(Nasdaq: HBIO) today announced thatJim Green, President and CEO, will present at the Singular Research Compelling Values 2020 Webinar onSeptember 17, 2020at 2:15 p.m. ET.   GlobeNewswire Inc
Aug 5, 2020
08:21AM EDT  Harvard Bioscience Q2 Adj. EPS $0.05 Beats $(0.03) Estimate, Sales $23.31M Beat $22.19M Estimate   Benzinga
07:00AM EDT  -- Operating Income up sequentially and year-over-year on both GAAP and adjusted basis -- Cost reduction programs offset expected declines in Academic markets -- Net Debt reduced by $2.2 million in Q2   GlobeNewswire Inc
04:21AM EDT  Earnings Scheduled For August 5, 2020   Benzinga
Jul 20, 2020
08:30AM EDT  Harvard Bioscience, Inc. (Nasdaq: HBIO) will announce its financial results for second quarter ended June 30, 2020 before the market opens on August 5, 2020, and will hold a conference call to discuss the results on August 5, 2020 at 8:00 a.m. Eastern Time.   GlobeNewswire Inc


Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2025 ChartExchange LLC